Dow Jones 11061.85 -7.37 4:37 pm PST, February 24, 2006  NASDAQ 2287.04 +7.72 For info, visit access.smallcapnetwork.com S & P 500 1289.43 +1.64 Change your subscription status here Russell 2000 736.60 +4.15 VOLUME 06: ISSUE 16  Pink Sheets vs. Bulletin Board - Know the Difference. Anyone who deals in the less well known and capitalized stock names has, by definition, a more robust risk tolerance than your standard 'widows and orphans" type investor. For that reason, these hearty high risk/reward types tend to gravitate toward the more speculative stocks. And their hosting Exchanges... There seems to be some confusion among readers regarding where Bulletin Board (OTCBB) and Pink Sheet (PS) stocks rank in the investment food chain. There are similarities, but also some significant differences. Both take listings by Market Maker subscription (instead of company application as on the big Exchanges) and are competitive quotation driven markets. While both markets are speculative, how a company gets to and stays on the OTCBB or the Pinks provides both the differentiation and ultimately the varying degrees of investment risk. While OTCBB stocks are regulated and are required to provide financial information by remaining current in their filings with the SEC, Pink Sheet stocks don't and can be a bit of a wild-west show. The Pink Sheets are basically just a competitive customer/market maker quotation service provided over the Internet and bereft of any reporting requirements. Any filing of financial documents is strictly voluntary. Accomplishing anything approaching due diligence by investors within that realm can be like riding a three legged horse. Pink Sheet investors have to virtually depend solely on the company for information, which could carry an unhealthy amount of bias. There is one trend, however, that is benefiting and growing listings on the Pink Sheets. Given the prohibitive cost and regulation associated with an ongoing listing on a larger Exchange--Sarbanes Oxley, etc.--more companies have opted to go to the more welcoming Pink Sheets in their formative stages. With $100's of thousands on the line to comply with an ever growing list of regulatory requirements, the cache of a legitimate Exchange listing may be just to onerous to a smaller company. The broad difference between the two markets is categorized thus: The OTC Bulletin Board® (OTCBB) is a regulated quotation service that displays real-time quotes, last-sale prices, and volume information in over-the-counter (OTC) equity securities. The Pink Sheets are not owned, operated or regulated by The NASDAQ Stock Market, Inc. or indeed any Exchange/regulatory entity. Pink Sheets LLC is a privately owned New York-based company delivering an Electronic Quotation Service, which only provides an Internet-based, real-time quotation service for OTC equities and bonds. Neither Exchange has listing requirements coming remotely close to their larger brethren. They are, indeed, subscription services as opposed to an issuer-listed exchange such as the NASDAQ, AMEX or NYSE. Basically, if you have the fee and a broker sponsor, you can list on the OTCBB or the Pinks.  The main strength to OTCBB over the Pinks is that if you see an ongoing quotation showing on an OTCBB stock, that means that it is current in its regulatory filings--a necessary component to remaining listed. If the company is late filing, an 'E' is attached to the quote symbol until the situation is rectified. If the company fails to file within the 30-60 day grace period, the security will be removed.  And likely moved, unceremoniously, to the unregulated, non-reporting Pink Sheets. Starting to make sense? Quotation of OTC securities on the Pink Sheets is subject to Rule 15c2-11. The issuer of the security may not apply to list or quote it on the Pink Sheets. It is a market maker that determines whether to quote an OTC security and initiates quotation by submitting a Form 211 to the NASD. Since there are no reporting requirements, it is actually possible for a market maker to quote securities in the Pink Sheets without the knowledge or permission of the issuer of the securities. While Rule 15c2-11 is also necessary for the OTCBB folks, ongoing SEC filings are required. It's pretty safe to assume that because of this reporting that the OTCBB companies have a more vested interest in the trading of their stocks as well as keeping shareholders informed. While the Pink Sheets has been categorized as the ugly stepsister of the market, the OTCBB is more like a second cousin of the NASDAQ. The main differences between the OTCBB and the NASDAQ is that the former: does not impose listing standards; does not provide automated trade executions; does not maintain relationships with quoted issuers; and does not have the same obligations for Market Makers. The OTCBB provides quotes on over 3300 securities through approximately 250 Market Makers. The NASDAQ has no dealings with OTCBB issuers; its role is to establish a fair and orderly market for its customers. Any beefs one may have with an OTCBB company goes through the SEC. The NASD deals with broker/trader conduct. The Pink Sheets, originally a dealer to dealer telephone market, derived its name from the color of the quotation sheet published and circulated daily for these mostly microcap, formative securities. Even I remember those... Up until a few years ago, with the advent of the Internet, there's a good chance most investors had never heard or dealt in the Pink Sheet world. Since then, its visibility has improved to a point that issues and volumes have increased exponentially. While this may have added to the 'legitimacy' of the Pink Sheets, investors need to be very cautious; mainly due to the lack of regulatory filing requirements as well as a pretty much complete dearth of ongoing news and objective information.  Caveat Emptor. Truly. Oh, and here are the OTC sites: http://www.otcbb.com and http://www.pinksheets.com Enjoy...   We Value Your Feedback Got comments, questions or suggestions? Send 'em on over: Editor@smallcapnetwork.com If you wish to send a written request or inquiry, please send it to our physical address: TGR Group, LLC 4653 Carmel Mtn Rd Suite 308 #402  San Diego, CA 92130 Whither the Russell 2000? Over the last two months, the Russell has put in a triple top at the 736 level, currently sitting at 733. Our feeling is that breaking above 736 without a fairly significant pullback is reasonably unlikely. Instead, the index will likely break down and clean up everyone below the 700 level prior to another leg up. While we are comfortable maintaining our long-term bullish stance on the Russell, we would only be buying on weakness in the short-term, primarily around the 690 level.   And Now, the Dow Micro-Cap Index. Dow Micro-Cap index ($DJSM) bottomed in October 2005 at 1018 and has since vaulted to its current level of 1200. Much like the Russell, the DJSM has also put in a triple top in the last few months and appears to also want to pullback before heading higher; providing  excellent buying opportunities in microcaps in the coming few months. We'd like to see the DJSM pull back to at least 1140 or so before jumping in. That would be an ideal entry point. Taking some profits off the table in small stocks is not a bad idea right now. And, although our short-term outlook is a little bearish, we remain very bullish in the long-term. Even when small stocks are out of favor, you can always find a few that will outperform the broader markets. That is our mandated goal regardless of market sentiment. The caveat is that if either of these two indices do happen to breach their triple tops in the near future without a pullback, then it's likely all aboard for a decent ride up.   CEL-SCI, NOVELOS; Looking Good Two biotechs in our stable appear to be acting very well currently. We Alerted the readership to CEL-SCI (AMEX: CVM) a couple of weeks back at 52-cents. Volumes have grown significantly and the price at 71-cents is showing over a 35 percent return already over the alert price. We feel that as it solidifies its Phase 3 and Phase 2 plans, the market will likely assign a higher price to the shares, which has a market cap well below its peers. Similarly therapeutics firm Novelos (OTCBB: NVLT) has also seen improved daily volumes and appears, in our opinion, poised for some decent upside. The company just submitted a proposal to the Federal Agency DHHS for the use of NOV-002 to treat subjects exposed to dirty bombs/lethal radiation. With the unique potential for this company and its treatments for cancer and hepatitis, the diversification of product efficacy should be of keen interest to investors. A Phase 3 Lung Cancer trial is slated to begin in the summer/fall of 2006, which should, like the aforementioned stock, raise the profile of NVLT with shareholders and move the market cap more in line with comparable peers. We like them both we think they have important products and should be owned at these levels both for the long-term and for any interim trading opportunities. Subscribe Information is power and timely information is profitable. Become informed and profit from SmallCapDigest Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the SmallCapDigest Email Newsletter on a regular basis. To ensure newsletter delivery, you can add any additional email addresses you may have to the SmallCapDigest Member List. Receiving the SmallCapDigest Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the SmallCapDigest recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery. Subscribe Here Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the SmallCapDigest, simply follow the instructions located at the bottom of every SmallCapDigest Newsletter Edition. Unsubscribe Here D I S C L A I M E R: The SmallCap Digest is an independent electronic publication committed to providing our readers with factual information on selected  publicly traded companies. SmallCap Digest is not a licensed investment professional or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward  maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features for the publication and circulation of the SmallCap Digest or representation on SmallCapNetwork.net.  Likewise, this newsletter is owned by TGR Group, LLC.  To the degrees enumerated herein,  this newsletter should not be regarded as an independent publication. Visit Here to view our compensation on every company we have ever covered, or visit the following web address:  http://access.smallcapnetwork.com/compensation_disclosure.html for our full compensation disclosure and http://access.smallcapnetwork.com/short_term_alerts.html for Trading Alerts compensation and disclosure. TGR Group LLC has been paid a fee of $25,000 and 150,000 shares of newly issued restricted stock by Cel-Sci for coverage of the Company. Additionally, TGR Group LLC has been paid a fee of $25,000 and 100,000 shares of newly issued restricted stock by Novelos for coverage of the Company. All statements and expressions are the sole  opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. From time to time TGR Group LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies. The editor, members of the editor's family, and/or entities with  which the editor is affiliated aside from TGR Group LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. The profiles, critiques, and other editorial content of the SmallCap Digest and SmallCapNetwork.net may contain statements that appear forward as it relates to the expected capabilities of the companies mentioned herein. Some of the companies featured in the SmallCap Digest Newsletter pay an ESP (Electronic Service Provider) fee of $2,500 per month to an affiliated Technology Company for electronic delivery of this newsletter and other web related technology services. THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF SMALLCAPNETWORK.NET. We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm . Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.